| Vir Biotechnology |
| Date/Time | / |
| Chg. / Chg.(%) | - / |
| Bid | - |
| Ask | - |
| Open | - |
| Previous Close | - |
| High | - |
| Low | - |
| Volume [USD] | - |
| Volume [Units] | |
| Price fixings | |
| ISIN | US92764N1028 |
| Security | VIR |
| Exchange | IEX |
| Type | Stock |
News
- US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA.2 Subvariant
03/25/2022 / 21:04 - GlobeNewswire - Vir Biotechnology to Participate in the 42nd Annual Cowen Healthcare Conference
03/02/2022 / 22:02 - GlobeNewswire - Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
02/24/2022 / 22:03 - GlobeNewswire - Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022
02/10/2022 / 22:02 - GlobeNewswire - Data Suggest Sotrovimab Retains Neutralizing Activity Against Omicron Subvariant BA.2
02/10/2022 / 07:24 - GlobeNewswire
Real-time